- Home
- MRSN vs CNTY Comparison
MRSN vs CNTY Comparison
Compare MRSN & CNTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRSN
- CNTY
- Stock Information
- Founded
- MRSN 2001
- CNTY 1992
- Country
- MRSN United States
- CNTY United States
- Employees
- MRSN N/A
- CNTY N/A
- Industry
- MRSN Biotechnology: Pharmaceutical Preparations
- CNTY Hotels/Resorts
- Sector
- MRSN Health Care
- CNTY Consumer Discretionary
- Exchange
- MRSN Nasdaq
- CNTY Nasdaq
- Market Cap
- MRSN 71.9M
- CNTY 80.4M
- IPO Year
- MRSN 2017
- CNTY 1993
- Fundamental
- Price
- MRSN $0.34
- CNTY $1.69
- Analyst Decision
- MRSN Buy
- CNTY Strong Buy
- Analyst Count
- MRSN 3
- CNTY 6
- Target Price
- MRSN $4.00
- CNTY $5.17
- AVG Volume (30 Days)
- MRSN 3.1M
- CNTY 122.7K
- Earning Date
- MRSN 03-03-2025
- CNTY 03-13-2025
- Dividend Yield
- MRSN N/A
- CNTY N/A
- EPS Growth
- MRSN N/A
- CNTY N/A
- EPS
- MRSN N/A
- CNTY N/A
- Revenue
- MRSN $40,497,000.00
- CNTY $575,919,000.00
- Revenue This Year
- MRSN N/A
- CNTY $11.83
- Revenue Next Year
- MRSN N/A
- CNTY $3.38
- P/E Ratio
- MRSN N/A
- CNTY N/A
- Revenue Growth
- MRSN 9.88
- CNTY 4.67
- 52 Week Low
- MRSN $0.34
- CNTY $1.64
- 52 Week High
- MRSN $4.64
- CNTY $5.09
- Technical
- Relative Strength Index (RSI)
- MRSN 29.11
- CNTY 23.60
- Support Level
- MRSN $0.41
- CNTY $1.75
- Resistance Level
- MRSN $0.42
- CNTY $1.88
- Average True Range (ATR)
- MRSN 0.04
- CNTY 0.15
- MACD
- MRSN -0.00
- CNTY -0.01
- Stochastic Oscillator
- MRSN 3.43
- CNTY 5.95
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company using its differentiated and proprietary ADC platforms to develop targeted drugs with increased tolerability and expanded opportunities to deliver meaningful clinical benefits to patients. The Company's early stage programs includes XMT-1660, a Dolasynthen ADC targeting B7-H4, as well as XMT-2056, a STING agonist ADC developed using the Company's Immunosynthen platform and targeting a novel epitope of human epidermal growth factor receptor 2. The Company also has two earlier stage preclinical candidates, XMT-2068 and XMT-2175, both of which leverage the Company's Immunosynthen platform and target tumor-associated antigens.
About CNTY Century Casinos Inc.
Century Casinos Inc is a casino entertainment company that develops and operates gaming establishments as well as related lodging, restaurant, horse racing (including off-track betting), and entertainment facilities in North America. The company has three reportable segments based on the geographical locations in which its casinos operate; United States; Century Casino & Hotel-Central City, and Century Casino & Hotel-Cripple Creek in Colorado, Mountaineer Casino, Racetrack & Resort in West Virginia, and Century Casino Caruthersville, and Century Casino Cape Girardeau in Missouri, Canada; Century Casino & Hotel, Century Casino St. Albert, Century Mile Racetrack in Edmonton and Casino Century Downs Racetrack and Casino in Calgary, and Poland; Casinos Poland.